| Allele Name | tm5023 |
| Balance | Not Required |
| OutCross | Not Accepted |
| Sequence Name | B0252.2 |
| Gene Name | asm-1 |
| Worm Base | Allele Name |
tm5023
|
| Gene Name |
asm-1
|
| Sequence |
B0252.2
|
Phenotype
Information from the receiver is posted in the form
of a "researcher : phenotype"
| homozygous viable. |
Mutation site
Please see gene structure to locate the deletion in
relation to exon(s)
| 11250/11251-TGTCC-11545/11546 (295 bp deletion + 5 bp insertion) |
| Chromosome | II |
| Putative gene structure | join(10488..10557, 10609..10693, 10736..10853, 11040..11595, 11641..11767, 12004..12084, 12136..12306, 12355..12457, 12504..12590, 12637..12821, 12869..12980) |
| Map position | 0.14 |
| Balancer | |
| Map position of balancer | |
| Sequence of primers | IntRev:CGATACTACTGTAGTGGTAC,ExtRev:GGTTATCAAAGGATGTGCGT,IntFwd:GGGCGGTCTGTGATGGAATT,ExtFwd:GCCAAACAACCATGGGCGGT |
| Distributed lab | |
| Depositor | Dr. S. Mitani/NBRP |
| References |
Please submit your publication
Hao L, Ben-David O, Babb SM, Futerman AH, Cohen BM, Buttner EA. Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans. Neuropsychopharmacology 2017 42(4) 951-962
[ PubMed ID = 27711049 ]
[ RRC reference ]
|
|